KY as A Cancer Drug Target and Biomarker (G339855)

Target Name: KY

NCBI ID: G339855

Content of Review Report on KY Target / Biomarker

KY as A Cancer Drug Target and Biomarker

KY (Ketogenic YDNA) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure, which consists of a long terminal repeat and a short stem-loop, has led to a high degree of computational complexity and a limited understanding of its function in living organisms.

The research on KY has been primarily focused on its potential role in cancer, with studies indicating that it may play a significant role in the regulation of cell proliferation and survival. Several studies have shown that KY can be expressed in various types of cancer cells and that it can inhibit the growth of these cells in cell culture and animal models. Additionally, several studies have identified that KY can be overexpressed in various types of cancer and that this overexpression can lead to increased cell proliferation and survival.

Another area of research for KY has been its potential as a biomarker for cancer. Several studies have shown that KY can be detected in various types of cancer tissues and that this detection may be associated with poor prognosis. Additionally, several studies have shown that KY can be downregulated in various types of cancer and that this downregulation may be associated with cancer progression and poor prognosis.

While the exact mechanism of how KY promotes cancer growth and survival is not yet fully understood, it is clear that it plays an important role in these processes. Further research is needed to determine the exact role of KY in cancer and to develop effective therapies that target it.

In conclusion, KY is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and the limited understanding of its function in living organisms make it a promising target for further research. Further studies are needed to determine the exact role of KY in cancer and to develop effective therapies that target it.

Protein Name: Kyphoscoliosis Peptidase

Functions: Probable cytoskeleton-associated protease required for normal muscle growth. Involved in function, maturation and stabilization of the neuromuscular junction. May act by cleaving muscle-specific proteins such as FLNC (By similarity)

The "KY Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KY comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets